Caroline E. Nunes‐Xavier

1.5k total citations
53 papers, 1.1k citations indexed

About

Caroline E. Nunes‐Xavier is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Caroline E. Nunes‐Xavier has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 21 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Caroline E. Nunes‐Xavier's work include Protein Tyrosine Phosphatases (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Caroline E. Nunes‐Xavier is often cited by papers focused on Protein Tyrosine Phosphatases (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Caroline E. Nunes‐Xavier collaborates with scholars based in Spain, Norway and United Kingdom. Caroline E. Nunes‐Xavier's co-authors include Rafael Pulido, Øystein Fodstad, Karine Flem‐Karlsen, José I. López, Ming Tan, Christina Tekle, J.C. Angulo, Pablo Ríos, Lydia Tabernero and Rocío Cejudo-Marín and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Caroline E. Nunes‐Xavier

51 papers receiving 1.1k citations

Peers

Caroline E. Nunes‐Xavier
Ruben Bill Switzerland
Michael K. Asiedu United States
Lucia Borriello United States
Caroline E. Nunes‐Xavier
Citations per year, relative to Caroline E. Nunes‐Xavier Caroline E. Nunes‐Xavier (= 1×) peers Rei Mizuno

Countries citing papers authored by Caroline E. Nunes‐Xavier

Since Specialization
Citations

This map shows the geographic impact of Caroline E. Nunes‐Xavier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline E. Nunes‐Xavier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline E. Nunes‐Xavier more than expected).

Fields of papers citing papers by Caroline E. Nunes‐Xavier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline E. Nunes‐Xavier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline E. Nunes‐Xavier. The network helps show where Caroline E. Nunes‐Xavier may publish in the future.

Co-authorship network of co-authors of Caroline E. Nunes‐Xavier

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline E. Nunes‐Xavier. A scholar is included among the top collaborators of Caroline E. Nunes‐Xavier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline E. Nunes‐Xavier. Caroline E. Nunes‐Xavier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nunes‐Xavier, Caroline E., et al.. (2025). Therapeutic Potential of Translational Readthrough at Disease‐Associated Premature Termination Codons From Tumor Suppressor Genes. IUBMB Life. 77(5). e70018–e70018. 2 indexed citations
2.
Amayra, Imanol, et al.. (2025). Novel CTNNB1 Gene Variants in Spanish CTNNB1 Syndrome Patients: Clinical and Psychological Manifestations. Journal of Autism and Developmental Disorders. 1 indexed citations
3.
Nunes‐Xavier, Caroline E., Sonia Bañuelos, Fabio Cavaliere, et al.. (2025). Genotype-phenotype characterization and functional reconstitution of pathogenic β-catenin variants from CTNNB1 syndrome patients. PLoS Genetics. 21(10). e1011907–e1011907.
4.
Amayra, Imanol, et al.. (2025). Cognitive and Adaptive Functioning of CTNNB1 Syndrome Patients: A Comparison With Autism Spectrum Disorder and Cerebral Palsy. Journal of Intellectual Disability Research. 69(7). 558–568. 1 indexed citations
5.
Lawrie, Charles H., María Armesto, Caroline E. Nunes‐Xavier, et al.. (2025). Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. 26(22). 11112–11112.
6.
Nunes‐Xavier, Caroline E., et al.. (2024). Potentiation by Protein Synthesis Inducers of Translational Readthrough of Pathogenic Premature Termination Codons in PTEN Isoforms. Cancers. 16(16). 2836–2836. 2 indexed citations
7.
Pulido, Rafael, José I. López, & Caroline E. Nunes‐Xavier. (2024). B7-H3: a robust target for immunotherapy in prostate cancer. Trends in cancer. 10(7). 584–587. 11 indexed citations
8.
Øyjord, Tove, Gunhild M. Mælandsmo, J.C. Angulo, et al.. (2024). Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma. OncoImmunology. 13(1). 2419686–2419686. 3 indexed citations
9.
Angulo, J.C., Gorka Larrinaga, Charles H. Lawrie, et al.. (2024). Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy. Cancers. 16(16). 2786–2786. 1 indexed citations
10.
López, José I., et al.. (2023). Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis. Immuno-Oncology Technology. 21. 100690–100690. 4 indexed citations
11.
Nunes‐Xavier, Caroline E., et al.. (2023). Novel anti-PTEN C2 domain monoclonal antibodies to analyse the expression and function of PTEN isoform variants. PLoS ONE. 18(8). e0289369–e0289369. 2 indexed citations
12.
Nunes‐Xavier, Caroline E., Laura Zaldumbide, Idoia Martín‐Guerrero, et al.. (2022). Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma. Cancers. 14(2). 421–421. 2 indexed citations
13.
Rodríguez‐Escudero, Isabel, Caroline E. Nunes‐Xavier, José I. López, et al.. (2022). Functional analysis of PTEN variants of unknown significance from PHTS patients unveils complex patterns of PTEN biological activity in disease. European Journal of Human Genetics. 31(5). 568–577. 4 indexed citations
14.
Amo, Laura, Isabel Rodríguez‐Escudero, Asier Erramuzpe, et al.. (2021). A global analysis of the reconstitution of PTEN function by translational readthrough ofPTENpathogenic premature termination codons. Human Mutation. 42(5). 551–566. 13 indexed citations
15.
Larrinaga, Gorka, et al.. (2021). (Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the Bladder. Cancers. 13(22). 5642–5642. 1 indexed citations
16.
Nunes‐Xavier, Caroline E., Wanja Kildal, Andreas Kleppe, et al.. (2021). Immune checkpoint B7‐H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer. The Prostate. 81(12). 838–848. 20 indexed citations
17.
Heras, Javier de las, Ibai Díez, A Cabrera, et al.. (2020). Brain Circuit Alterations and Cognitive Disability in Late-Onset Cobalamin D Disorder. Journal of Clinical Medicine. 9(4). 990–990. 2 indexed citations
18.
Nunes‐Xavier, Caroline E., et al.. (2019). Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation. International Journal of Molecular Sciences. 20(5). 1170–1170. 12 indexed citations
19.
Gaafar, Ayman, Caroline E. Nunes‐Xavier, Isabel Guerra, et al.. (2019). Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology. npj Precision Oncology. 3(1). 11–11. 15 indexed citations
20.
Pulido, Rafael, Laura Zaldumbide, Asier Erramuzpe, et al.. (2017). Neuroblastoma PTPome analysis unveils association of DUSP5 and PTPN1 expression with poor prognosis. Annals of Oncology. 28. vii21–vii21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026